Search

everythinglearnresearchcommunity

for

Search:↓

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Alopecia can be caused by multicentric reticulohistiocytosis.

CARASIL can cause different symptoms even with the same genetic mutation.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Rathke’s cleft cysts can rarely cause Cushing disease, and surgery can improve symptoms.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

A new compound shows promise as a topical treatment for hair loss.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Hydroxytyrosol helps reduce liver injury by blocking certain inflammation pathways.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Social media can help compare the effectiveness and safety of new arthritis medications.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.